MTOR and cerebral cavernous malformation: 2023). In addition, J. Ren et al. (2023) found that MAP3K3 gain‐of‐function mutation can independently stimulate the mTOR signaling pathway, thereby causing CCM in mice, which mirrored human sporadic CCM in pathology.